Ângela Maria Bagattini

Ms. Ângela Maria Bagattini


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Value in Health Regional Issues
Verified
Journal Article
Closed access
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
SCSuzi Alves Camey
Suzi Alves Camey
SMSandro René Miguel
Sandro René Miguel
MAMônica Viegas Andrade
Mônica Viegas Andrade
KNKenya Valeria Micaela de Souza Noronha
Kenya Valeria Micaela de Souza Noronha
LCLuciane Nascimento Cruz
Luciane Nascimento Cruz

9 June 2022 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
JBJosé Luiz Alvim Borges
José Luiz Alvim Borges
RRRachel Riera
Rachel Riera
DCDébora Cecília Mantovani Faustino de Carvalho
Débora Cecília Mantovani Faustino de Carvalho
An increase in the use of automated systems has optimised the drug dispensing process in hospitals. This case study describes the implementation of automated drug dispensing system and presents the preliminary results of automated pharmaceutical dispensing with robots (PillPick® and BoxPicker®, ©Swisslog Healthcare) at Hospital Sírio-Libanês, a private tertiary hospital in Brazil. During the study period, between 2013 (pre-automation) and 2017 (post-automation) the number total of medication errors has not changed post-automation, but there was significant reduction in error in the dispensing phase with a relative risk of 0.84 (95% confidence interval: 0.70–0.99) withal a reduction in the numbers of returned items, breakages, and loss of medications, although that delivery times have increased.. The study results suggest that the use of robotic systems in the central pharmacy may improve hospital pharmacy management and generate only a few errors in dispensing pharmaceuticals.

29 November 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
RRRachel Riera
Rachel Riera
RPRafael Leite Pacheco
Rafael Leite Pacheco
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
AMAna Luiza Cabrera Martimbianco
Ana Luiza Cabrera Martimbianco

24 September 2019 in CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIO
Verified
Journal Article
Open access
PDF file
RRRachel Riera
Rachel Riera
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
DPDaniela Pachito
Daniela Pachito
Objective: to discuss the regulatory process of drugs for rare diseases in Brazil, based on the Zolgensma® case, and to critically evaluate the evidence so far available on the efficacy and safety of Zolgensma® for treating spinal muscular atrophy (SMA). Methods: descriptive study conducted at the Health Technology Assessment Center of the Sírio Libanês Hospital (NATS-HSL) in June 2019. Results: in April 2019, the use of Zolgensma® for SMA was regulated in the United States based on two open-lable (unmasked), non-comparative (and therefore non-randomized) studies. These methodological limitations increase the uncertainty related to study results. The National Agency of Sanitary Surveillance (Anvisa) has approved strategies to regulate the process and specific deadlines for completing the appraisal process of new medicines for rare diseases, such as Zolgensma®. Conclusion: it is necessary to broaden the debate about the process of regulation and incorporation of orphan drugs for rare diseases in Brazil. This debate should include evidence related to the effects (benefits and risks) of these drugs, and greater transparency of the criteria indispensable for granting registration and recommendation of incorporation into health systems.

1 January 2021 in Vaccine
Verified
Journal Article
Open access
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
GPGabriela Policena
Gabriela Policena
RMRuth Minamisava
Ruth Minamisava
AAAna Lucia S. Andrade
Ana Lucia S. Andrade
SNSérgio de A. Nishioka
Sérgio de A. Nishioka
CTCristiana M Toscano
Cristiana M Toscano
Pertussis is associated with significant disease burden in children worldwide. In addition to its cyclical nature, resurgences of pertussis cases, hospitalizations and deaths have been reported by many countries. We describe the dynamics of pertussis in Brazil, a middle-income country that has experienced a resurgence and that provides good quality data to allow building a dynamic transmission disease model. We conducted a descriptive analysis of pertussis burden considering data from the national disease surveillance system, national hospitalization information system and national mortality registry. Study period was 2000-2016. Absolute numbers and rates per 100,000 inhabitants over time, by age sub-groups and geographical regions are presented. From 2000 to 2016, a total of 37,299 reported pertussis cases, 25,240 hospitalizations, and 601 deaths due to pertussis were reported. Although the outcomes - pertussis cases, hospitalizations, and deaths - come from independent information systems, our results document low disease burden with periodic increases every 3-4 years during the years 2000-2010, followed by a sharp increase which peaked in 2014. In both periods, disease burden is concentrated in young children, while its more serious outcomes - hospitalizations and deaths, are concentrated in infants. Pre-outbreak and outbreak disease burden as well as timing of peak during the outbreak period vary by states and within geographical regions, representing valuable resources of data for modelling purposes. Consistent disease burden patterns were observed over time in Brazil using a variety of data sources. Given the scarcity of good epidemiological data on pertussis available from low- and middle-income countries, our reported data provide valuable information for the assessment of the public health impact and cost-effectiveness modelling studies of newer strategies to prevent and control pertussis. These data were used to build and calibrate a national dynamic transmission model, which was used to evaluate the cost-effectiveness of maternal immunization. Clinical Trial registry name and registration number: Not applicable.

13 December 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
GAGabriel Berg de Almeida
Gabriel Berg de Almeida
LSLorena Mendes Simon
Lorena Mendes Simon
ÂBÂngela Maria Bagattini
Ângela Maria Bagattini
MMICHELLE ROSA
MICHELLE ROSA
MBMarcelo Eduardo Borges
Marcelo Eduardo Borges
CTCristiana Maria Toscano
Cristiana Maria Toscano
Brazil was one of the countries most affected during the first year of the COVID-19 pandemic, in a pre-vaccine era, and mathematical and statistical models were used in decision-making and public policies to mitigate and suppress SARS-CoV-2 dispersion. In this article, we intend to overview the modeling for COVID-19 in Brazil, focusing on the first 18 months of the pandemic. We conducted a scoping review and searched for studies on infectious disease modeling methods in peer-reviewed journals and gray literature, published between January 01, 2020, and June 2, 2021, reporting real-world or scenario-based COVID-19 modeling for Brazil. We included 81 studies, most corresponding to published articles produced in Brazilian institutions. The models were dynamic and deterministic in the majority. The predominant model type was compartmental, but other models were also found. The main modeling objectives were to analyze epidemiological scenarios (testing interventions’ effectiveness) and to project short and long-term predictions, while few articles performed economic impact analysis. Estimations of the R0 and transmission rates or projections regarding the course of the epidemic figured as major, especially at the beginning of the crisis. However, several other outputs were forecasted, such as the isolation/quarantine effect on transmission, hospital facilities required, secondary cases caused by infected children, and the economic effects of the pandemic. This study reveals numerous articles with shared objectives and similar methods and data sources. We observed a deficiency in addressing social inequities in the Brazilian context within the utilized models, which may also be expected in several low- and middle-income countries with significant social disparities. We conclude that the models were of great relevance in the pandemic scenario of COVID-19. Nevertheless, efforts could be better planned and executed with improved institutional organization, dialogue among research groups, increased interaction between modelers and epidemiologists, and establishment of a sustainable cooperation network.